Astonea Labs Incorporates 51%-Owned Subsidiary Longevity Science
Astonea Labs Ltd · Others (Uncategorized) · 08 Oct 2026, 10:41 pm
Astonea Labs Incorporates 51%-Owned Subsidiary Longevity Science Astonea Labs Limited announced the incorporation of a new subsidiary, Longevity Science Private Limited, on 8th Oct'26. The company will acquire a 51% controlling stake by subscribing to 51,000 initial equity shares at ₹10 each, totaling a cash consideration of ₹5,10,000 on an arm's-length basis. The newly incorporated entity will operate in the pharmaceuticals, healthcare, nutraceuticals, and allied products sector in India. No specific regulatory approvals are required beyond standard statutory filings.
Original exchange filing (PDF)
More announcements from Astonea Labs Ltd
- Non-Applicability of Statement of Deviation & Variation for the half year ended 30th September, 2026 · 15 Nov 2026
- Revised Outcome of Board Meeting held on 14th November, 2026 · 15 Nov 2026
- Unaudited Financial Results (Standalone & Consolidated) for the half year ended 30th September, 2026 · 14 Nov 2026
- Outcome of Board Meeting held on 14th November, 2026 · 14 Nov 2026
- Astonea Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve unaudited Standalone and Consolidated .... · 14 Nov 2026
- Please find enclosed herewith an Intimation regarding change in the Corporate Identification Number (CIN) of the Company consequent upon alteration of the Object Clause of the Memorandum .... · 09 Oct 2026
- Please find enclosed herewith re-submission of financial results for the half year and year ended 31.03.2025. · 22 Sept 2026
- Please find enclosed herewith resubmission of financial results for the financial year ended 31.03.2025, as the same was submitted in XBRL Version and as a part of outcome of the Board .... · 19 Sept 2026
